EX-2.3
from 10-12B
100 pages
Membership Interest Purchase Agreement by and Among Biohaven Therapeutics Ltd., Knopp Biosciences LLC, Channel Biosciences, LLC and Biohaven Pharmaceutical Holding Company Ltd., Solely for the Purpose of Section 9.14 Dated as of February 24, 2022 Certain Confidential Information Contained in This Document, Marked by [**], Has Been Omitted Because It Is Both (I) Not Material and (II) the Type the Registrant Treats as Private or Confidential
12/34/56
EX-2.1
from 10-12B
77 pages
Separation and Distribution Agreement by and Among Biohaven Pharmaceutical Holding Company Ltd., Biohaven Research Ltd., And, Solely With Respect to Section 2.7(b), Section 2.10, Section 4.2, Section 4.3, Section 4.5(c), Section 4.7, Section 5.1(a), Section 6.6(i), Section 8.3, Section 8.6, and Section 8.7, Pfizer Inc. Dated as of May 9, 2022
12/34/56
EX-2.1
from DRS
77 pages
Separation and Distribution Agreement by and Among Biohaven Pharmaceutical Holding Company Ltd., Biohaven Research Ltd., And, Solely With Respect to Section 2.7(b), Section 2.10, Section 4.2, Section 4.3, Section 4.5(c), Section 4.7, Section 5.1(a), Section 6.6(i), Section 8.3, Section 8.6, and Section 8.7, Pfizer Inc. Dated as of May 9, 2022
12/34/56
